1-3 of 3
Richard Brandl
Close
Sort by
Journal Articles

Targeting platelet-derived CXCL12 impedes arterial thrombosis

Julian Leberzammer, Stijn M. Agten, Xavier Blanchet, Rundan Duan, Hans Ippel, Remco T. A. Megens, Christian Schulz, Maria Aslani, Johan Duchene, Yvonne Döring, Natalie J. Jooss, Pengyu Zhang, Richard Brandl, Konstantin Stark, Wolfgang Siess, Kerstin Jurk, Johan W. M. Heemskerk, Tilman M. Hackeng, Kevin H. Mayo, Christian Weber, Philipp von Hundelshausen
Journal: Blood
Blood (2022) 139 (17): 2691–2705.
https://doi.org/10.1182/blood.2020010140
Published: 2022
Includes: Multimedia, Supplemental data
Journal Articles

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans

Kristina Busygina, Janina Jamasbi, Till Seiler, Hans Deckmyn, Christian Weber, Richard Brandl, Reinhard Lorenz, Wolfgang Siess
Journal: Blood
Blood (2018) 131 (24): 2605–2616.
https://doi.org/10.1182/blood-2017-09-808808
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

Human Atheromatous Plaques Stimulate Thrombus Formation by Activating Platelet Glycoprotein VI.

Armin J. Reininger, MD, PhD, Richard Brandl, MD, Sandra Penz, Pankaj Goyal, Tamer Rabie, Enno Rother, Christine Goetz, Bernd Engelmann, MD, Richard Farndale, PhD, Bernhard Nieswandt, MD, Wolfgang Siess, MD
Journal: Blood
Blood (2004) 104 (11): 2623.
https://doi.org/10.1182/blood.V104.11.2623.2623
Published: 2004